DAILY UPDATE
February 25, 2020
Dear Valued Reader,

Today I spent some time digging into the latest Stansberry Venture Value pitch, all about Cloud SaaS stocks and how hugely appealing they can be as they perform like "tech royalties" with their high margins and scalability.  Hard to argue with that, though so many of them are so pricey... but which specific ones are they teasing?  I ID the first one for you today, and it actually appealed enough to me that I bought a few shares, too, just click below to...


Five hundred miles outside of Silicon Valley, this obscure company is about to unleash a radical technology worth more than $10 trillion. It’s so obscure, in fact, that it trades under a code name. But 77 million Americans are about to get their hands on this tiny company’s groundbreaking technology. And some investors could make a small fortune.  Click here to get all of the details before this tech goes mainstream.


Advertisement

Every investor dreams of waking up in the mornign to find that the stock they own got a takeover offer and the share price has doubled, so there are always pundits predicting who that next 'takeover target' will be... this time around, it's Dylan Jovine who's teasing his "#1 takeover target for February" -- and if that's not enough, it's also an Alzheimer's Disease stock... so what's the stock, and what's the story?  Just click below to...


IRREGULARS CORNER

Feb 21
Feb 14
Feb 13
Feb 7
Feb 6
Feb 1
Jan 24
Jan 17
Dec 20
Dec 13
Dec 11
Dec 6
Nov 22
Nov 15
Nov 8
Nov 5
Nov 1
Oct 25
Oct 24
Oct 18
Oct 11
Oct 4












 

Stock Gumshoe | travis@stockgumshoe.com | www.stockgumshoe.com
351 Pleasant St., Suite B #205, Northampton, MA 01060
Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

Having trouble viewing this email? Read the web version.

You may unsubscribe if you no longer wish to receive our emails. We have no wish to email people who don't want to receive these messages. Please note that unsubscribing applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.